Tyme Technologies : Annual Report (Form 10-K) : vimarsana.co

tyme-10k_20220331.htm

Table of Contents



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549



... | May 25, 2022

Related Keywords

New York , United States , Japan , United Kingdom , Texas , Florida , Delaware , California , Santa Monica , Washington , Canada , Russia , Ukraine , Germany , New Jersey , Monte Carlo , Bedminster , Maryland , France , Georgetown University , District Of Columbia , Americans , America , American , Janm Van Tornout , Barbarac Galaini , James Biehl , Jonathan Eckard , Timothyc Tyson , Jan Van Tornout , Frank Mongiello , Sant Chawla , Steve Hoffman , Frank Porfido , Michael Demurjian , Richard Cunningham , Trickett Wendler , Us Congress , Revenue Service , Health Care Reform Lawarealsoinvalid On , Investor Relations Department , Transaction Committee , Us Court , Us District Court , Trademark Office , While The Company , International Regulation , Global Group Enterprises Corp , Exchange Agreements , Public Company Accounting Oversight Board United States , Centers For Disease , Exchange Agreement , Centers For Medicare Medicaid Services , Tyme Inc , World Health Organization , Contract Clinical Research Organization , European Organisation For Research , Exchange Agreement See Historical Financings , Health Care , Key Product Properties , Contract Service Providers , Health Care Reform Cadillac , Joseph Ahmed Foundation , Tumor Targeting Technology , Incorporation Or Organization , Seriesa Preferred Stock Of The Company , Drug Administration Modernization , Eu Commission , Health Care Reform Law On , Liability Company , Tyme Technologies Inc , Medicaid Services , Division Of Oncology , Medicaid Drug Rebate Program , Share Exchange Agreements , Smaller Reporting Company , Us Department Of Health , Preclinical Pipeline Program , Pancreatic Cancer Action Network , Committee On Deficit Reduction , Health Care Reform , Trust Company , Public Health Service , European Medicines Agency , Fast Track Program , Office Of Oncologic Diseases , Public Health Service Act , Office Of Inspector , Health Insurance Portability , Nasdaq , Development Expenses , Clinical Health Act , Centers For Medicare , Ethics Committee , Strategic Planning Committee Of The Board , Moelis Company , Clinical Health , Department Of Justice , Drug Administration , Children Health Insurance Program , European Commission , Eagle Pharmaceuticals , Data Monitoring Committee , Syneos Health , Exchange Commission , Health Care Reform Lawis , Health Care Reform Lawmarketplace , Florida As Global Group Enterprises Corp , Securities Exchange , Texas Us District Court , Us Department Of Justice , Commission File No , Biomarker Research , Tymeand Eagle Pharmaceuticals Inc , Clinical Research Funding , Drug Administration Safety , Portfolio Development Strategy , European Union , Health Care Reform Law , Corporation Law , Public Company Accounting Oversight Board , United States Department Of Health , Health Information Technology For Economic , Compassionate Use Program , Eagle Pharmaceuticals Inc , Human Services , Growth Company , District Court , Sarcoma Oncology Center , Scientific Affairs , Company Common Stock , Eastern Cooperative Oncology Group Performance Status , Outcomes Research Institute , Exact Name , Its Charter , Principal Executive Offices , Zip Code , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Proxy Statement , Annual Report , Tyme Technologies , Insurance Portability , Accountability Act , Information Technology , States Department , Economic Security , Sponsoring Organizations , Treadway Commission , Drug Administration Modernization Act , Cosmetic Act , Oxley Act , States Patent , Strategic Options , Strategic Planning Committee , Member Timothy , Cancer After , Data Monitor , Principal Investigator , Mayo Clinic , Investigational New Drugs , Use Patients , Clinical Benefit , Compassionate Use Patients , Trial Reported , Panc Part , Discontinuing Programs , Metastatic Pancreatic Cancer , Precision Promise , Development Strategy , Warburg Effect , Federal Food , Oncologic Diseases , Standard Review , Related Requirements , Innovation Act , Breakthrough Therapy , Breakthrough Therapy Designation , Hatch Waxman Act , Abbreviated New Drug Application , Napproved Drug Products , Therapeutic Equivalence Evaluations , Orange Book , Orange Book Listed , Orphan Drug Act , Healthcare Laws , Compliance Requirements , Inspector General , Drug Master Files , Corporate Governance Guidelines , Securities Purchase Agreement , Co Promotion Agreement , Global Group Enterprises , Corporate History , Significant Organizational , One Pluckemin Way , Market Sales , Open Market Sale , Common Stock ,